Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...

Researchers from IIT Madras and Ohio State University have developed an AI framework called PURE that can quickly generate drug-like molecules suitable for real-world synthesis. This innovation aims ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to ...